Zyrex Healthcare Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 26-10-2024
- Paid Up Capital ₹ 1.00 M
as on 26-10-2024
- Company Age 2 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
About Zyrex Healthcare
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 1.00 M, as per Ministry of Corporate Affairs (MCA) records.
Samiksha Gaikwad, Samir Gaikwad, Mrudula Wattamwar, and One other member serve as directors at the Company.
- CIN/LLPIN
U24304PN2022PTC213780
- Company No.
213780
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Aug 2022
- Date of AGM
30 Dec 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Company Details
- Location
Pune, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Zyrex Healthcare?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samir Gaikwad  | Director | 10-Aug-2022 | Current |
| Samiksha Gaikwad | Director | 10-Aug-2022 | Current |
| Mrudula Wattamwar | Additional Director | 06-Feb-2024 | Current |
| Raman Wattamwar | Additional Director | 06-Feb-2024 | Current |
Financial Performance of Zyrex Healthcare.
Zyrex Healthcare Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Zyrex Healthcare?
Unlock access to Zyrex Healthcare's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Sameeksha Pharmaceuticals Private LimitedActive 8 years 7 monthsSamiksha Gaikwad and Samir Gaikwad are mutual person
- Humano Forte Services Private LimitedActive 1 year 1 month
Mrudula Wattamwar and Raman Wattamwar are mutual person
- Rtm Healthcare Private LimitedActive 7 years 2 days
Mrudula Wattamwar and Raman Wattamwar are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Zyrex Healthcare?
Zyrex Healthcare has a workforce of 0 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Zyrex Healthcare, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Zyrex Healthcare's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
